1. Home
  2. EVAX vs YGMZ Comparison

EVAX vs YGMZ Comparison

Compare EVAX & YGMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVAX
  • YGMZ
  • Stock Information
  • Founded
  • EVAX 2008
  • YGMZ 2002
  • Country
  • EVAX Denmark
  • YGMZ China
  • Employees
  • EVAX N/A
  • YGMZ N/A
  • Industry
  • EVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • YGMZ Transportation Services
  • Sector
  • EVAX Health Care
  • YGMZ Consumer Discretionary
  • Exchange
  • EVAX Nasdaq
  • YGMZ Nasdaq
  • Market Cap
  • EVAX 8.7M
  • YGMZ 7.0M
  • IPO Year
  • EVAX 2021
  • YGMZ 2020
  • Fundamental
  • Price
  • EVAX $2.62
  • YGMZ $0.71
  • Analyst Decision
  • EVAX Strong Buy
  • YGMZ
  • Analyst Count
  • EVAX 3
  • YGMZ 0
  • Target Price
  • EVAX $33.33
  • YGMZ N/A
  • AVG Volume (30 Days)
  • EVAX 6.8M
  • YGMZ 58.2K
  • Earning Date
  • EVAX 03-26-2025
  • YGMZ 01-01-0001
  • Dividend Yield
  • EVAX N/A
  • YGMZ N/A
  • EPS Growth
  • EVAX N/A
  • YGMZ N/A
  • EPS
  • EVAX N/A
  • YGMZ N/A
  • Revenue
  • EVAX $3,295,000.00
  • YGMZ $55,805,416.00
  • Revenue This Year
  • EVAX $4,845.21
  • YGMZ N/A
  • Revenue Next Year
  • EVAX $30.30
  • YGMZ N/A
  • P/E Ratio
  • EVAX N/A
  • YGMZ N/A
  • Revenue Growth
  • EVAX N/A
  • YGMZ N/A
  • 52 Week Low
  • EVAX $2.22
  • YGMZ $0.64
  • 52 Week High
  • EVAX $23.70
  • YGMZ $6.24
  • Technical
  • Relative Strength Index (RSI)
  • EVAX 41.09
  • YGMZ 36.53
  • Support Level
  • EVAX $2.22
  • YGMZ $0.64
  • Resistance Level
  • EVAX $4.05
  • YGMZ $0.75
  • Average True Range (ATR)
  • EVAX 1.17
  • YGMZ 0.08
  • MACD
  • EVAX 0.00
  • YGMZ -0.00
  • Stochastic Oscillator
  • EVAX 6.99
  • YGMZ 20.16

About EVAX Evaxion Biotech

Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.

About YGMZ MingZhu Logistics Holdings Limited

MingZhu Logistics Holdings Ltd is a Holding company. Its business activities include trucking services and car owner services. Its segments are the trucking business, car owner services business, and liquor distribution business. It generates the majority of its revenue from the trucking segment.

Share on Social Networks: